Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether brain oxygenation measured by cerebral oximeter has an impact on neurocognitive dysfunction.
| Condition | Intervention | Phase |
|---|---|---|
|
Post-Operative Delirium Postoperative Cognitive Dysfunction |
Procedure: SctO2 < 60 %. |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Caregiver, Investigator) Primary Purpose: Prevention |
| Official Title: | Tailored Patient Management Guided With Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery. |
- The association of Postoperative Delirium (PD) and Postoperative Cognitive Dysfunction (POCD) with changes in cerebral tissue oxygen saturation (SctO2). [ Time Frame: First 5 days after the cardiac surgery. ] [ Designated as safety issue: No ]
- Postoperative Morbidity and Mortality [ Time Frame: 3 months postoperatively ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 120 |
| Study Start Date: | September 2009 |
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Cerebral Desaturation, i.e; SctO2 < 60 % for 5 minutes
Once the cerebral desaturation is established, the study personnel will attempt to optimize the level of oxygen within the brain of the study patients.
|
Procedure: SctO2 < 60 %.
The following intervention protocol will be applied when SctO2 level falls below 60 %. First, the patients head position will be checked for suitable position and the face will be observed for plethora. Then the efforts will be made to maintain PaCO2 between 40-50 mmHg and MAP of 60 - 80 mm Hg. Cardiac index will be maintained between 2.0 - 2.5 L/min/m2. The hematocrit should be more than 20 %. The red blood cells or hemoconcentration will be used for this purpose.
|
|
No Intervention: Patients with SctO2 less than 60 %.
The study patients will not get any intervention in this arm if the Sct02 falls below 60%
|
Detailed Description:
Both postoperative delirium (PD) and postoperative cognitive dysfunction (POCD) are well known complications seen in elderly patients after cardiac surgery. The etiologies of PD and POCD are unknown, but cerebral ischemia remains a prime candidate. Attempts to correlate reduced levels of systemic oxygenation (i.e. SpO2) with the development of PD/POCD have been to date disappointing.
We believe that cerebral oximetry, a noninvasive technology that continuously monitors cerebral tissue oxygen saturation (SctO2), will enable us to answer the question of whether or not a correlation exists.
The availability of an absolute cerebral oximeter (FORE-SIGHT), with its ability to establish and manipulate threshold values for SctO2, provides us the opportunity to assess the relationship between cerebral oxygenation and the development of neurocognitive complications.
We propose a randomized, masked trial of 120 patients, adequately powered to assess the following:
- Is there an association between deficits in cerebral oxygenation and the occurrence of PD at some time in the 1st 5 days after the operation?
- Is there an association between deficits in cerebral oxygenation and changes in POCD scores shortly (5 days) after the operation and/or 4-6 weeks later? We hypothesize that individually tailored patient management guided with intraoperative and postoperative absolute cerebral oximetry monitoring using a tailored protocol designed to maintain SctO2 values above a specific threshold will result in improved neurocognitive outcomes in geriatric patients undergoing cardiac surgery.
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 65 and older
- Elective cardiac or thoracic aortic surgery
- Capable and willing to consent
- Participants literate in English
Exclusion Criteria:
- Emergency Surgery
- Major Neurological Disease
- Gross Cognitive Dysfunction
- Patients not expected to be able to complete the 1 week and 3 months post-operative visit.
Contacts and Locations| Contact: Gregory Fischer, M.D. | 212-241-7749 | gregory.fischer@mountsinai.org |
| Contact: Dionne Bobb, M.S, CCRC | dionne.bobb@mountsinai.org |
| United States, New York | |
| Mount Sinai School of Medicine | Not yet recruiting |
| New York, New York, United States, 10029 | |
| Contact: Gregory Fischer, M.D. 212-241-7749 gregory.fischer@mountsinai.org | |
| Contact: Ajay Satayapriya, M.D. ajay.satyapriya@mountsinai.org | |
| Principal Investigator: Gregory Fischer, M.D. | |
| Sub-Investigator: Ajay Satayapriya, M.D. | |
| Sub-Investigator: Muhammad Nauman, M.D. | |
| Mount Sinai School of Medicine | Recruiting |
| New York, New York, United States, 10029 | |
| Contact: Gregory Fischer, M.D. 212-241-7749 gregory.fischer@mountsinai.org | |
| Contact: Muhammad Nauman, M.D. 212-241-7749 muhammad.nauman@mountsinai.org | |
| Principal Investigator: Gregory Fischer, M.D. | |
| Principal Investigator: | Gregory Fischer, M.D. | Mount Sinai School of Medicine |
More Information
Publications:
| Responsible Party: | Gregory Fischer, MD, Mount Sinai School of Medicine (MSSM) |
| ClinicalTrials.gov Identifier: | NCT00991328 History of Changes |
| Other Study ID Numbers: | GCO # 07-0332 |
| Study First Received: | October 2, 2009 |
| Last Updated: | October 7, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Mount Sinai School of Medicine:
|
PD POCD Post-op Delirium (PD) Post-op Cognitive Dysfunction (POCD) |
Additional relevant MeSH terms:
|
Delirium Cognition Disorders Confusion Neurobehavioral Manifestations Neurologic Manifestations |
Nervous System Diseases Signs and Symptoms Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013